Baxter International Inc.
BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care productā¦ read more
Healthcare
Medical Instruments & Supplies
44 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$17.31
Price-3.24%
-$0.58
1Y
Price
Market Cap
$8.940b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+11.2%
EBITDA Margin-0.6%
Net Profit Margin+2.8%
Free Cash Flow Margin+11.2%
EBITDA Margin-0.6%
Net Profit Margin+2.8%
Free Cash Flow MarginRevenue
$11.320b
+0.7%
1y CAGR+3.0%
3y CAGR+3.0%
5y CAGREarnings
-$1.098b
-14.7%
1y CAGR-62.2%
3y CAGR+5.6%
5y CAGREPS
-$2.10
-20.0%
1y CAGR-60.7%
3y CAGR+6.6%
5y CAGRBook Value
$6.016b
$19.846b
Assets$13.830b
Liabilities$9.687b
DebtDebt to Assets
48.8%
13x
Debt to EBITDAFree Cash Flow
$714m
+121.1%
1y CAGR+7.4%
3y CAGR+36.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company